Publications by authors named "L Stoll"

Together with obesity and type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global epidemic. Activation of the complement system and infiltration of macrophages has been linked to progression of metabolic liver disease. The role of complement receptors in macrophage activation and recruitment in MASLD remains poorly understood.

View Article and Find Full Text PDF

The immune system coordinates the response to cardiac injury and controls regenerative and fibrotic scar outcomes in the heart and subsequent chronic low-grade inflammation associated with heart failure. Adult mice and humans lack the ability to fully recover while adult zebrafish spontaneously regenerate after heart injury. Here we profile the inflammatory response to heart cryoinjury in zebrafish and coronary artery ligation in mouse using single cell transcriptomics.

View Article and Find Full Text PDF

Endometriosis, characterized by the ectopic implantation of endometrial tissue, typically involves pelvic structures but infrequently extends to extrapelvic sites such as the gastrointestinal tract. In this report, we present a case of a 44-year-old woman with diffuse abdominal discomfort and constipation. Computed tomography imaging revealed a mass in the cecum, leading to diagnostic colonoscopy and subsequent magnetic resonance imaging.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly common alongside obesity and type 2 diabetes, with a link to immune responses involving complement proteins and macrophages.
  • The study investigates the role of the complement 3a receptor (C3aR1) in macrophages, particularly in the liver's Kupffer cells, by creating mouse models lacking this receptor.
  • Results show that deleting C3aR1 in macrophages or Kupffer cells doesn't significantly impact liver conditions like steatosis, inflammation, or fibrosis in the context of a MASLD-inducing diet.
View Article and Find Full Text PDF

Excessive adiposity in obesity is a significant risk factor for development of type 2 diabetes (T2D), nonalcoholic fatty liver disease, and other cardiometabolic diseases. An unhealthy expansion of adipose tissue (AT) results in reduced adipogenesis, increased adipocyte hypertrophy, adipocyte hypoxia, chronic low-grade inflammation, increased macrophage infiltration, and insulin resistance. This ultimately culminates in AT dysfunction characterized by decreased secretion of antidiabetic adipokines such as adiponectin and adipsin and increased secretion of proinflammatory prodiabetic adipokines including RBP4 and resistin.

View Article and Find Full Text PDF